A detailed history of Capital Counsel LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Capital Counsel LLC holds 471,179 shares of IDXX stock, worth $195 Million. This represents 10.24% of its overall portfolio holdings.

Number of Shares
471,179
Previous 470,099 0.23%
Holding current value
$195 Million
Previous $229 Million 3.9%
% of portfolio
10.24%
Previous 10.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$455.08 - $517.19 $491,486 - $558,565
1,080 Added 0.23%
471,179 $238 Million
Q2 2024

Aug 14, 2024

BUY
$468.04 - $548.53 $254,613 - $298,400
544 Added 0.12%
470,099 $229 Million
Q1 2024

May 15, 2024

SELL
$515.08 - $576.87 $177,702 - $199,020
-345 Reduced 0.07%
469,555 $254 Million
Q4 2023

Feb 14, 2024

SELL
$391.37 - $557.56 $927,546 - $1.32 Million
-2,370 Reduced 0.5%
469,900 $261 Million
Q3 2023

Nov 13, 2023

SELL
$432.42 - $556.67 $314,369 - $404,699
-727 Reduced 0.15%
472,270 $207 Million
Q2 2023

Aug 14, 2023

SELL
$450.7 - $503.61 $1.59 Million - $1.77 Million
-3,524 Reduced 0.74%
472,997 $238 Million
Q1 2023

May 15, 2023

SELL
$406.01 - $514.59 $5.82 Million - $7.38 Million
-14,345 Reduced 2.92%
476,521 $238 Million
Q4 2022

Feb 09, 2023

BUY
$324.64 - $441.27 $530,461 - $721,035
1,634 Added 0.33%
490,866 $200 Million
Q3 2022

Nov 14, 2022

BUY
$325.8 - $407.78 $1.11 Million - $1.39 Million
3,416 Added 0.7%
489,232 $159 Million
Q2 2022

Aug 15, 2022

BUY
$327.37 - $553.44 $4.28 Million - $7.23 Million
13,064 Added 2.76%
485,816 $170 Million
Q1 2022

May 16, 2022

BUY
$466.52 - $631.01 $44,785 - $60,576
96 Added 0.02%
472,752 $259 Million
Q4 2021

Feb 14, 2022

BUY
$586.54 - $666.48 $553,693 - $629,157
944 Added 0.2%
472,656 $311 Million
Q3 2021

Nov 12, 2021

SELL
$621.9 - $705.76 $22.9 Million - $26 Million
-36,769 Reduced 7.23%
471,712 $293 Million
Q2 2021

Aug 12, 2021

SELL
$486.36 - $637.08 $3.88 Million - $5.09 Million
-7,984 Reduced 1.55%
508,481 $321 Million
Q1 2021

May 12, 2021

SELL
$465.18 - $551.79 $9.49 Million - $11.3 Million
-20,400 Reduced 3.8%
516,465 $253 Million
Q4 2020

Feb 10, 2021

SELL
$383.85 - $499.87 $3.98 Million - $5.19 Million
-10,378 Reduced 1.9%
536,865 $268 Million
Q3 2020

Nov 16, 2020

SELL
$334.54 - $406.31 $22.7 Million - $27.6 Million
-67,806 Reduced 11.02%
547,243 $215 Million
Q2 2020

Aug 14, 2020

SELL
$230.66 - $330.16 $7.01 Million - $10 Million
-30,389 Reduced 4.71%
615,049 $203 Million
Q1 2020

May 15, 2020

SELL
$182.94 - $290.97 $5.07 Million - $8.06 Million
-27,707 Reduced 4.12%
645,438 $156 Million
Q4 2019

Feb 14, 2020

SELL
$248.66 - $285.01 $5.25 Million - $6.02 Million
-21,112 Reduced 3.04%
673,145 $176 Million
Q3 2019

Nov 14, 2019

BUY
$260.07 - $289.93 $1.73 Million - $1.93 Million
6,641 Added 0.97%
694,257 $189 Million
Q2 2019

Aug 14, 2019

BUY
$215.53 - $275.33 $371,573 - $474,668
1,724 Added 0.25%
687,616 $189 Million
Q1 2019

May 15, 2019

BUY
$178.02 - $225.69 $586,041 - $742,971
3,292 Added 0.48%
685,892 $153 Million
Q4 2018

Feb 13, 2019

SELL
$176.18 - $248.92 $555,847 - $785,342
-3,155 Reduced 0.46%
682,600 $127 Million
Q3 2018

Nov 14, 2018

SELL
$218.82 - $254.46 $9.06 Million - $10.5 Million
-41,402 Reduced 5.69%
685,755 $171 Million
Q2 2018

Aug 14, 2018

SELL
$185.56 - $227.9 $2.48 Million - $3.04 Million
-13,347 Reduced 1.8%
727,157 $158 Million
Q1 2018

May 14, 2018

SELL
$157.81 - $204.73 $351,127 - $455,524
-2,225 Reduced 0.3%
740,504 $142 Million
Q4 2017

Feb 13, 2018

BUY
$147.68 - $168.37 $1.43 Million - $1.63 Million
9,666 Added 1.32%
742,729 $116 Million
Q3 2017

Nov 14, 2017

BUY
$150.32 - $166.46 $110 Million - $122 Million
733,063
733,063 $114 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.4B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Capital Counsel LLC Portfolio

Follow Capital Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Counsel LLC with notifications on news.